Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2022-10-05 | Amended | $6,486,036 | $6,486,036 | Equity Only | 06b | SEC link |
| 2022-05-23 | Amended | $6,725,000 | $0 | Equity Only | 06b | SEC link |
| 2022-05-19 | New | Yet to Sell | $0 | Equity Only | 06b | SEC link |
| 2022-05-17 | Amended | $6,725,000 | $5,675,000 | Equity Only | 06b | SEC link |
| 2021-12-17 | New | $1,050,000 | $1,050,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Meeshanthini Dogan | Director, Executive |
| Warren Hosseinion | Director |
| Elisa Luqman | Executive |
| Robert Philibert | Director, Executive |